"Biotechnology's Response to the Burgeoning Medical-Marijuana Industry"
LAS VEGAS, NV--(Marketwired - Sep 11, 2014) - Growblox Sciences, Inc. (
Link: Huffington Post Article
The company's feature in the Huffington Post reviews the following:
About GrowBLOX Sciences, Inc.: GrowBLOX Sciences, Inc. (
About Forward-Looking Statements:
This Press Release may contain certain forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Growblox Sciences, Inc. has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect Growblox Sciences, Inc. current beliefs and are based on information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause Growblox Sciences, Inc. actual results, performance or achievements to differ materially from those expressed in or implied by such statements. Growblox Sciences, Inc. undertakes no obligation to update or provide advice in the event of any change, addition or alteration to the information contained in this Press Release including such forward-looking statements.
*PR and Editorial Services by 1800PublicRelations.com
Contact Information:
Contacts
Company Contact:
Growblox Sciences, Inc.
7251 West Lake Mead Blvd Suite 300
Las Vegas, NV 89128
+1 (844) 843-2569
www.growbloxsciences.com
Press/Media Contact:
Matthew BIRD
President
1-800-PublicRelations.com, Inc.
+1 (917) 409-8211
matt.bird@1800pr.com
www.1800PublicRelations.com